Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines
- PMID: 10708411
- PMCID: PMC111795
- DOI: 10.1128/jvi.74.7.2973-2980.2000
Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines
Abstract
An SK6 cell line (SK6c26) which constitutively expressed the glycoprotein E(rns) of classical swine fever virus (CSFV) was used to rescue CSFV E(rns) deletion mutants based on the infectious copy of CSFV strain C. The biochemical properties of E(rns) from this cell line were indistinguishable from those of CSFV E(rns). Two E(rns) deletion mutants were constructed, virus Flc23 and virus Flc22. Virus Flc23 encoded only the utmost N- and C-terminal amino acids of E(rns) (deletion of 215 amino acids) to retain the original protease cleavage sites. Virus Flc22 is not recognized by a panel of E(rns) antibodies, due to a deletion of 66 amino acids in E(rns). The E(rns) deletion mutants Flc22 and Flc23 could be rescued in vitro only on the complementing SK6c26 cells. These rescued viruses could infect and replicate in SK6 cells but did not yield infectious virus. Virus neutralization by E(rns)-specific antibodies was similar for the wild-type virus and the recombinant viruses, indicating that E(rns) from SK6c26 cells was incorporated in the viral particles. Pigs vaccinated with Flc22 or Flc23 were protected against a challenge with a lethal dose of CSFV strain Brescia. This is the first demonstration of trans-complementation of defective pestivirus RNA with a pestiviral structural protein and opens new ways to develop nontransmissible modified live pestivirus vaccines. In addition, the absence of (the antigenic part of) E(rns) in the recombinant viral particles can be used to differentiate between infected and vaccinated animals.
Figures




Similar articles
-
Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.Vaccine. 2002 Feb 22;20(11-12):1544-56. doi: 10.1016/s0264-410x(01)00497-2. Vaccine. 2002. PMID: 11858861
-
Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.Vaccine. 2000 Oct 15;19(4-5):447-59. doi: 10.1016/s0264-410x(00)00198-5. Vaccine. 2000. PMID: 11027808
-
Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.Vet Res. 2006 Sep-Oct;37(5):655-70. doi: 10.1051/vetres:2006028. Epub 2006 Jun 17. Vet Res. 2006. PMID: 16777037
-
The challenges of classical swine fever control: modified live and E2 subunit vaccines.Virus Res. 2014 Jan 22;179:1-11. doi: 10.1016/j.virusres.2013.10.025. Epub 2013 Nov 6. Virus Res. 2014. PMID: 24211665 Review.
-
Cardioviral poly(C) tracts and viral pathogenesis.Arch Virol Suppl. 1994;9:67-77. doi: 10.1007/978-3-7091-9326-6_8. Arch Virol Suppl. 1994. PMID: 8032283 Review.
Cited by
-
Single-Round Infectious Particle Production by DNA-Launched Infectious Clones of Bungowannah Pestivirus.Viruses. 2020 Aug 4;12(8):847. doi: 10.3390/v12080847. Viruses. 2020. PMID: 32759644 Free PMC article.
-
Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.J Virol. 2002 Oct;76(20):10138-46. doi: 10.1128/jvi.76.20.10138-10146.2002. J Virol. 2002. PMID: 12239288 Free PMC article.
-
Establishment and characterization of an infectious cDNA clone of a classical swine fever virus LOM strain.J Vet Sci. 2012 Mar;13(1):81-91. doi: 10.4142/jvs.2012.13.1.81. J Vet Sci. 2012. PMID: 22437540 Free PMC article.
-
Determinants of virulence of classical swine fever virus strain Brescia.J Virol. 2004 Aug;78(16):8812-23. doi: 10.1128/JVI.78.16.8812-8823.2004. J Virol. 2004. PMID: 15280489 Free PMC article.
-
Bungowannah Pestivirus Chimeras as Novel Double Marker Vaccine Strategy against Bovine Viral Diarrhea Virus.Vaccines (Basel). 2022 Jan 7;10(1):88. doi: 10.3390/vaccines10010088. Vaccines (Basel). 2022. PMID: 35062749 Free PMC article.
References
-
- Bouma A, de Smit A J, de Kluijver E P, Terpstra C, Moormann R J. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet Microbiol. 1999;66:101–114. - PubMed
-
- Colijn E O, Bloemraad M, Wensvoort G. An improved ELISA for the detection of serum antibodies directed against classical swine fever virus. Vet Microbiol. 1997;59:15–25. - PubMed
-
- De Smit, A. J., H. G. P. Van Gennip, G. K. W. Miedema, P. A. Van Rijn, C. Terpstra, and R. J. M. Moormann. Recombinant pestiviruses derived from the Chinese vaccine strain (C-strain) of classical swine fever retain their avirulent and immunological characteristics. Vaccine, in press. - PubMed
-
- Edwards S, Moennig V, Wensvoort G. The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses. Vet Microbiol. 1991;29:101–108. - PubMed
-
- Hulst M M, Himes G, Newbigin E, Moormann R J. Glycoprotein E2 of classical swine fever virus: expression in insect cells and identification as a ribonuclease. Virology. 1994;200:558–565. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources